Actively Recruiting
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Led by University Hospital, Toulouse · Updated on 2026-03-19
5000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its persistence (i.e. downstream), while also specifying the risk of worsening renal failure (risk stratification, intolerance to the treatment or complications (infectious, metabolic, cardiovascular, cancer…). Nephrogene 2.0 aims to study these different components of kidney, immune and solid organ transplantation (SOT)-related diseases.
CONDITIONS
Official Title
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old with kidney disease or at risk of developing kidney disease
- Patients followed by a practitioner in the Department of Nephrology and Organ Transplantations at the University Hospital of Toulouse (France)
You will not qualify if you...
- Patient denies consent
- Patient or their family is unable to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rangueil University Hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
S
Stanislas Faguer, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here